Tag: thyroid drug
Tribunal upholds £84 million fine on Advanz Pharma, PE firms over drug price inflation
Advanz Pharma, alongside London-based private equity firms Cinven and HgCapital, is collectively confronted with an £84 million penalty for inflating the price of the...
CMA slaps Advanz with £100 million in fines for over pricing of thyroid drug
The Competition and Markets Authority (CMA) has imposed more than £100 million in fines on Advanz for inflating the price of thyroid tablets.
The pharma...